Published in J Nucl Med on March 30, 2017
Fiji: an open-source platform for biological-image analysis. Nat Methods (2012) 56.92
FSL. Neuroimage (2011) 15.56
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44
Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology (1990) 6.12
Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst (2000) 5.14
Stereotactic biopsy of diffuse pontine lesions in children. J Neurosurg (2007) 3.66
Comparison and evaluation of retrospective intermodality brain image registration techniques. J Comput Assist Tomogr (1997) 2.76
Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment. Radiology (2009) 2.55
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet (2014) 2.42
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol (2015) 2.04
Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. AJNR Am J Neuroradiol (2011) 2.00
Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure. Radiology (2013) 2.00
Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology (1982) 1.99
Pediatric brain stem gliomas: a review. Int J Radiat Oncol Biol Phys (1998) 1.58
Variability in PET quantitation within a multicenter consortium. Med Phys (2010) 1.46
Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications. Acta Neuropathol (2014) 1.46
Nuclear magnetic resonance (NMR) measurement of the apparent diffusion coefficient (ADC) of tissue water and its relationship to cell volume changes in pathological states. Neurochem Int (2004) 1.44
Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology (1995) 1.42
Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol (2003) 1.29
Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg (1985) 1.27
ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma. Neuroradiology (2010) 1.20
Results of positron emission tomography guidance and reassessment of the utility of and indications for stereotactic biopsy in children with infiltrative brainstem tumors. J Neurosurg (2007) 1.18
Discrimination of paediatric brain tumours using apparent diffusion coefficient histograms. Eur Radiol (2011) 1.15
The Neuroimaging Center of the Pediatric Brain Tumor Consortium-collaborative neuroimaging in pediatric brain tumor research: a work in progress. AJNR Am J Neuroradiol (2007) 1.15
Apparent diffusion and fractional anisotropy of diffuse intrinsic brain stem gliomas. AJNR Am J Neuroradiol (2010) 1.14
MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro Oncol (2011) 1.11
Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro Oncol (2014) 1.08
Paediatric brain-stem gliomas: MRI, FDG-PET and histological grading correlation. Pediatr Radiol (2006) 1.04
Establishment and results of a magnetic resonance quality assurance program for the pediatric brain tumor consortium. Acad Radiol (2008) 0.99
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013. Neuro Oncol (2016) 0.95
Quantitative diffusion-weighted and dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging analysis of T2 hypointense lesion components in pediatric diffuse intrinsic pontine glioma. AJNR Am J Neuroradiol (2010) 0.93
Metrics and textural features of MRI diffusion to improve classification of pediatric posterior fossa tumors. AJNR Am J Neuroradiol (2013) 0.92
Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma. J Neurooncol (2014) 0.91
Pediatric brain tumor consortium multisite assessment of apparent diffusion coefficient z-axis variation assessed with an ice-water phantom. Acad Radiol (2014) 0.88
Exploratory evaluation of two-dimensional and three-dimensional methods of FDG PET quantification in pediatric anaplastic astrocytoma: a report from the Pediatric Brain Tumor Consortium (PBTC). Eur J Nucl Med Mol Imaging (2008) 0.85
Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism. J Child Neurol (2015) 0.81
Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium. Neuro Oncol (2015) 0.80
Diffusion tensor histogram analysis of pediatric diffuse intrinsic pontine glioma. Biomed Res Int (2014) 0.80